Video Gallery

Opening Remarks
	Opening Remarks Dr. Kazuya Shimoda

Basic Science
	Elucidation of Molecular Pathophysiology of Myeloproliferative Neoplasms and Its Application to Therapeutic Decisions Dr. Robert Kralovics
	Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasm Dr. Marito Araki
	Fibrocytes in Myelofibrosis Dr. Kazuya Shimoda

Clinical Practice, Diagnostic and Treatment Strategy
	Long-term Interferon Treatment for Polycythemia Vera Dr. Richard Silver
	Objectives of Polycythemia Vera Treatment Dr. Srdan Verstovsek
	Halting Progression of Polycythemia Vera - Importance of Disease Burden Measurement Dr. Ruben Mesa
	Management of MPNs in Pregnancy Dr. Yoko Edahiro
	Chronic Myeloid Leukemia and Treatment in China Dr. Qian Jiang
	Diagnostic Challenges in Early MPN, MDS/MPN Overlaps, and New Molecular Data Dr. Hans Michael Kvasnicka
	Novel Mechanism-based Advances in the Treatment of MPNs Dr. John Mascarenhas

Interferon: History, Current Status and Future Prospects
	Interferon History Dr. Keita Kirito
	Ropeginterferon as an Early Treatment Dr. Heinz Gisslinger
	High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alfa-2b in PV Dr. Jean-Jacques Kiladjian
	Compassionate Use of Ropeginterferon Alfa-2b in Taiwan Dr. Chih-Cheng Chen
	Interferon Treatment for Chronic Myeloid Leukemia Dr. Dong-Wook Kim
	Interferon Treatment for Adult T-cell Leukemia/Lymphoma Dr. Akifumi Takaori-Kondo

Panel Disccusion
	Panel Discussion Dr. Lee-Yung Shih

Closing Remaks
	Closing Remarks Dr. Kazuya Shimoda